Hvilken er prisen på Liminal BioSciences Inc. (LMNL)

Prisen på Liminal BioSciences Inc. (LMNL) er $8.50

Hva er markedsverdien på Liminal BioSciences Inc. (LMNL)

Markedsverdien på Liminal BioSciences Inc. (LMNL) er $719.10K

Liminal BioSciences Inc. (LMNL) Inntekter

Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm, primarily engaged in creating innovative small molecule drug therapies. The company concentrates on addressing inflammatory, fibrotic, and metabolic diseases, with its operations spanning Canada and the United Kingdom. Its flagship drug candidate, fezagepras (identified as PBI-4050), has successfully advanced through Phase I clinical trials. This agent, along with its related derivatives, is undergoing investigation for potential application in treating idiopathic fibrosis affecting the lungs, liver, heart, or skin, as well as various respiratory conditions. Furthermore, Liminal is advancing antagonist programs, including G-protein coupled receptor 84 (GPR84) and Oxo-eicosanoid receptor 1 (OXER1), both of which are currently in preclinical development. Formerly known as Prometic Life Sciences Inc., the company adopted the name Liminal BioSciences Inc. in October 2019. Established in 1994, its corporate headquarters are located in Laval, Canada.

År	Inntekter	Endre
Ikke nok data for de angitte datoene.

År

Inntekter

Endre

Ikke nok data for de angitte datoene.

Selskap	Inntekter	Forskjell i inntekter	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$12.62B	-	US
Argenx SE ARGX.US	$6.02B	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	$10.11B	-	BE

Selskap

Inntekter

Forskjell i inntekter

Land